Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The Standard for Clinicians' Interview in Psychiatry (SCIP): A Clinician-administered Tool with Categorical, Dimensional, and Numeric Output-Conceptual Development, Design, and Description of the SCIP.

Aboraya A, Nasrallah H, Muvvala S, El-Missiry A, Mansour H, Hill C, Elswick D, Price EC.

Innov Clin Neurosci. 2016 Jun 1;13(5-6):31-77. Review.

2.

Does Biology Transcend the Symptom-based Boundaries of Psychosis?

Pearlson GD, Clementz BA, Sweeney JA, Keshavan MS, Tamminga CA.

Psychiatr Clin North Am. 2016 Jun;39(2):165-74. doi: 10.1016/j.psc.2016.01.001. Review.

PMID:
27216897
3.

Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence.

Greenberg WM, Citrome L.

Neurol Ther. 2015 Dec;4(2):81-91. doi: 10.1007/s40120-015-0030-4.

4.

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.

Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL; Schizophrenia Working Group of Psychiatric Genomics Consortium.; Bipolar Disorder Working Group of Psychiatric Genomics Consortium.; Cross-Disorder Working Group of Psychiatric Genomics Consortium., Gejman PV, O'Donovan MC, Andreassen OA, Djurovic S, Hultman CM, Kelsoe JR, Jamain S, Landén M, Leboyer M, Nimgaonkar V, Nurnberger J, Smoller JW, Craddock N, Corvin A, Sullivan PF, Holmans P, Sklar P, Kendler KS.

Mol Psychiatry. 2014 Sep;19(9):1017-24. doi: 10.1038/mp.2013.138.

5.

A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale.

Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, Eack SM, Tamminga C.

Schizophr Res. 2011 Dec;133(1-3):250-4. doi: 10.1016/j.schres.2011.09.005.

6.

Role of paliperidone extended-release in treatment of schizoaffective disorder.

Canuso CM, Turkoz I, Fu DJ, Bossie CA.

Neuropsychiatr Dis Treat. 2010 Oct 5;6:667-79. doi: 10.2147/NDT.S12612.

7.

McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.

Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, Maggini C.

J Clin Psychiatry. 2011 Feb;72(2):183-93. doi: 10.4088/JCP.09m05311yel.

8.

The role of genetics in the etiology of schizophrenia.

Gejman PV, Sanders AR, Duan J.

Psychiatr Clin North Am. 2010 Mar;33(1):35-66. doi: 10.1016/j.psc.2009.12.003. Review.

9.

Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.

Abrams DJ, Rojas DC, Arciniegas DB.

Neuropsychiatr Dis Treat. 2008 Dec;4(6):1089-109.

10.

Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes.

Lencz T, Lipsky RH, DeRosse P, Burdick KE, Kane JM, Malhotra AK.

Br J Psychiatry. 2009 Apr;194(4):313-8. doi: 10.1192/bjp.bp.108.050401.

11.

McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.

Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, Maggini C.

J Clin Psychiatry. 2009 Apr;70(4):458-66.

12.

The concept of psychosis: historical and phenomenological aspects.

Bürgy M.

Schizophr Bull. 2008 Nov;34(6):1200-10. doi: 10.1093/schbul/sbm136.

13.

Symptom dimensions and outcome in schizophrenia.

Salokangas RK.

World Psychiatry. 2003 Oct;2(3):172-8.

Supplemental Content

Support Center